Plasma Levels of Enzalutamide and Its Main Metabolites in a Metastatic Castration-Resistant Prostate Cancer Patient Undergoing Hemodialysis
Clinical Genitourinary Cancer - United States
doi 10.1016/j.clgc.2018.12.004
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
Elsevier BV